OC3.03.8 IS FECAL CALPROTECTIN A MARKER FOR MUCOSAL HEALING DURING INFLIXIMAB THERAPY?

Autor:	M. Rea, M. Di Pierro, M. Schettino, G. Caravelli, S. Monastra, F. Morace, G. Amalfi, G. Vespere, C. Farinato, V. D'Angelo
Rok vydání:	2008
Předmět:	Infliximab therapy medicine.medical_specialty Hepatology business.industry Mucosal healing Internal medicine Gastroenterology Medicine Calprotectin business Feces
Zdroj:	Digestive and Liver Disease. 40:S44-S45
ISSN:	1590-8658
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a8e75877b48a2b560848ddbe7235aa85 https://doi.org/10.1016/s1590-8658(08)60113-9 Zobrazit plný text záznamu Full Text from ScienceDirect